| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,562 |
9,668 |
$717K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,019 |
11,212 |
$633K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,882 |
2,774 |
$227K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,176 |
2,056 |
$225K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,386 |
5,080 |
$216K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,805 |
1,727 |
$133K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,696 |
1,631 |
$128K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,101 |
1,064 |
$91K |
| 99401 |
|
3,346 |
3,252 |
$91K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
459 |
423 |
$36K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,630 |
1,281 |
$24K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
87 |
40 |
$16K |
| 94760 |
|
10,120 |
9,432 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,675 |
1,594 |
$15K |
| 99383 |
|
124 |
117 |
$9K |
| 76140 |
|
165 |
149 |
$8K |
| 99050 |
|
426 |
401 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
258 |
235 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
109 |
103 |
$3K |
| 99384 |
|
34 |
30 |
$3K |
| 99382 |
|
14 |
14 |
$1K |
| 90671 |
|
58 |
53 |
$671.36 |
| 87807 |
|
100 |
94 |
$555.29 |
| 87428 |
|
29 |
28 |
$453.11 |
| 81002 |
|
173 |
159 |
$282.64 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
15 |
$253.51 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
14 |
13 |
$227.59 |
| 94664 |
|
16 |
15 |
$169.73 |
| 99177 |
|
22 |
21 |
$57.42 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
110 |
99 |
$37.50 |
| 90686 |
|
536 |
481 |
$15.15 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
16 |
15 |
$11.95 |
| 99174 |
|
19 |
19 |
$10.02 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
16 |
15 |
$4.20 |
| 99072 |
|
1,243 |
1,135 |
$0.00 |
| 90633 |
|
430 |
423 |
$0.00 |
| 90715 |
|
180 |
178 |
$0.00 |
| 90710 |
|
450 |
431 |
$0.00 |
| 90700 |
|
67 |
65 |
$0.00 |
| 90670 |
|
627 |
605 |
$0.00 |
| 99173 |
|
157 |
149 |
$0.00 |
| 90734 |
|
22 |
22 |
$0.00 |
| 90619 |
|
131 |
131 |
$0.00 |
| 90696 |
|
74 |
70 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |
| 90647 |
|
106 |
99 |
$0.00 |
| 90651 |
|
155 |
154 |
$0.00 |
| 90698 |
|
14 |
13 |
$0.00 |
| 90680 |
|
32 |
32 |
$0.00 |
| 90733 |
|
206 |
198 |
$0.00 |
| 90723 |
|
65 |
60 |
$0.00 |